Endpoints News 生物医药· Kyle LaHucik·· 2026-10-03AI 评分57
地理性萎缩药企 Aviceda 因 II 期失败将关停
Geographic atrophy biotech Aviceda to shut down after Phase 2 fail
AI 导读
地理性萎缩药企 Aviceda Therapeutics 因 II 期临床试验失败将关停公司。正文提到该企业原计划今年将一款眼部药物推进至 III 期,但此前中期临床数据出现挫折,报道在正文处被订阅墙截断。
正文
Aviceda Therapeutics, a biotech that had planned to take an eye drug into Phase 3 this year despite a mid-stage clinical setback, is in the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news